Hypertrophic Cardiomyopathy (HCM): Options fo...

Ashish Sarraju, MD, and Leslie Cho, MD, discuss key updates in the 2026 ACC/AHA cholesterol guidelines, including earlier LDL screening and integration of the PREVENT risk calculator. They explore clinical implications of Lp(a) testing, risk stratification and expanding therapeut ...  Show more

Michael Zhen-Yu Tong, MD, and Sanjeeb Bhattacharya, MD, discuss the clinical management of heart transplant patients during the first year, including immunosuppression strategies, rejection surveillance and complication recognition. They also highlight evolving technologies, dono ...  Show more

CardioNerds (Drs. Teodora Donisan, Jenna Skowronski, and Johnny Hourmozdi) discuss Cardiomyopathies with Dr. Steve Ommen. Through a case-based discussion, we review the diagnostic evaluation of suspected restrictive cardiomyopathy, and Dr. Ommen shares his expertise in the nuance ...  Show more

Obstructive hypertrophic cardiomyopathy therapy and septal reduction therapy via alcohol septal ablation and surgical myectomy is discussed by interventional cardiologist Dr. Amar Krishnaswamy and surgical perspective from cardiothoracic surgeon Dr. Per Wierup. Amit joins Dr. Lau ...  Show more

The CardioNerds discuss a case of hypertrophic cardiomyopathy teaching a comprehensive approach to pathophysiology, diagnosis, imaging, and management of hypertrophic cardiomyopathy. Guest host, Dr. Fatimah Alkhunaizi. Flutter moment by Dr. Virginia Hahn (Cardiology). On the Card ...  Show more

This episode considers a new treatment for hypertrophic cardiomyopathy, the world’s most common inherited heart condition, which most affected people don’t even realize they have. A full transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2400702.